Form 4: Liquidia CHRO Sells Over 16,000 Shares for $617,918

Liquidia Corp's Chief Human Resource Officer, Sarah Krepp, reported the sale of 16,261 shares of common stock at $38 per share.

Summary

• Sarah Krepp, Chief Human Resource Officer of Liquidia Corp (LQDA), sold 16,261 shares of common stock.
• The transaction occurred on March 13, 2026, with shares sold at a price of $38 each.
• The total value of the shares sold was $617,918.
• Following this transaction, Ms. Krepp beneficially owns 148,397 shares of Liquidia Corp common stock.
• The remaining beneficial ownership includes 28,857 unvested RSUs from a January 11, 2024 grant, 7,787 unvested RSUs from a July 1, 2024 grant, 38,145 unvested RSUs from a January 11, 2025 grant, 25,000 unvested RSUs from a July 1, 2025 grant, and 23,728 unvested RSUs from a January 16, 2026 grant.
• Additionally, the beneficial ownership includes 5,749 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, the relatively small percentage of total holdings sold and the significant remaining unvested equity suggest it is likely for personal financial management rather than a lack of confidence in the company's future.

Positives

• The Chief Human Resource Officer retains a significant beneficial ownership of 148,397 shares, including a substantial portion of unvested Restricted Stock Units (RSUs), indicating continued long-term alignment with shareholder interests.

Negatives

• An insider sale, even if for personal liquidity or tax planning, can sometimes be perceived by the market as a reduction in direct equity exposure by a key executive.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as this sale by a Chief Human Resource Officer, are common disclosures in the biotech and pharmaceutical sectors. While individual sales can be for personal financial planning, the market often scrutinizes such activities for broader signals about management's confidence in the company's near-term prospects, especially in a sector sensitive to clinical trial results and regulatory approvals.

Comparison to Industry Standards

• Insider sales of this magnitude (approximately $618,000) by a CHRO are not uncommon across industries for personal financial management or tax planning, and do not inherently signal a significant shift in company outlook when a substantial portion of equity holdings remains, particularly in unvested forms.
• Compared to other biotech executives, the remaining beneficial ownership, heavily weighted towards unvested RSUs, aligns with typical long-term incentive structures designed to retain key talent and align interests with future company performance.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal, though the impact is likely limited given the context of remaining holdings. Transparency of the transaction is maintained through the Form 4 filing.

Key Dates

Recommendation

The sale of 16,261 shares by the Chief Human Resource Officer, while notable, represents a relatively small portion of her total beneficial ownership, which still includes a substantial amount of unvested Restricted Stock Units. This suggests the sale is likely for personal financial planning rather than a fundamental change in company outlook. Without additional context or a pattern of widespread insider selling, this single transaction does not warrant a strong 'buy' or 'sell' recommendation, thus a 'hold' is appropriate as investors should monitor future filings and company performance.

Keywords

Liquidia Corp, LQDA, Insider Trading, Form 4, Stock Sale, Executive Compensation, Sarah Krepp, Chief Human Resource Officer